Stock TNYA TENAYA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Tenaya Therapeutics, Inc.

Equities

TNYA

US87990A1060

Market Closed - Nasdaq
Other stock markets
 04:00:07 2024-07-12 pm EDT 		5-day change 1st Jan Change
3.495 USD -0.14% Intraday chart for Tenaya Therapeutics, Inc. +19.69% +7.87%
Jul. 01 Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell Microcap Growth Index CI
Jul. 01 Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell 2500 Growth Index CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell Microcap Growth Index
CI
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell 2500 Growth Index
CI
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell 3000E Growth Index
CI
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell 3000 Growth Index
CI
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell 2000 Growth Index
CI
Tenaya Therapeutics, Inc.(NasdaqGS:TNYA) added to Russell Small Cap Comp Growth Index
CI
Tenaya Therapeutics Announces Research Leadership Updates
AQ
Tenaya Therapeutics, Inc. Announces Research Leadership Updates
CI
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
AQ
William Blair Starts Tenaya Therapeutics With Outperform Rating
MT
Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating
MT
Tenaya Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
AQ
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
AQ
Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating
MT
North American Morning Briefing : Stock Futures -2-
DJ
Tenaya Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
AQ
Tenaya Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TNYA Stock
  4. News Tenaya Therapeutics, Inc.